"Lutetium_Lu_177-DOTA-Chimeric_Monoclonal_Antibody_cG250"^^ . "Lutetium Lu-177 GirentuximabPTNCI" . . "Lutetium Lu-177 Girentuximab"^^ . "Pharmacologic Substance"^^ . "Lutetium Lu-177 Girentuximab"^^ . "Lutetium-177 Labeled cG250SYNCI" . "C1881485"^^ . "177Lu-DOTA-cG250ABNCI" . . "531051"^^ . "C66978"^^ . "531051"^^ . "Lutetium Lu-177-DOTA-Chimeric Monoclonal Antibody cG250SYNCI" . "A radioimmunoconjugate consisting of the chimeric monoclonal antibody cG250 linked to the low energy beta-emitting radioisotope Lutetium 177, via the bifunctional macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA), with potential antineoplastic activity. The antibody moiety of lutetium Lu-177-DOTA-chimeric monoclonal antibody cG250 binds to renal cell carcinoma (RCC) cells expressing the RCC-associated antigen G250; a cytotoxic dose of beta radiation is selectively delivered to G250-expressing RCC cells upon internalization of the radioimmunoconjugate.NCI" .